Request availability and a quotation for your required quantity and destination.
| Product | Finasteride 5 mg - Proscar |
|---|---|
| Categories | Hair Care |
| Availability | Confirmed on enquiry |
Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.
Product category: Hair Care
Active ingredient: Finasteride 5 mg
Dosage form: Oral tablet
Prescription: Required
Proscar contains finasteride, a 5-alpha-reductase inhibitor. The 5 mg strength is chiefly indicated for benign prostatic hyperplasia (BPH) rather than routine treatment of hair loss. Its placement in a Hair Care catalogue does not change its approved indication. A clinician should confirm suitability and dosing.
Finasteride blocks conversion of testosterone to dihydrotestosterone (DHT), a hormone linked to androgenetic hair thinning and prostate enlargement. Treatment effects depend on the diagnosis and patient characteristics.
In men with enlarged prostates, 5 mg finasteride can improve urinary symptoms and reduce risks associated with BPH over time. This does not mean the 5 mg strength is more appropriate for hair loss.
Reported effects include reduced libido, erectile or ejaculation changes, breast symptoms and mood changes. Finasteride alters prostate-specific antigen (PSA) results and requires interpretation during prostate screening. A possible association with high-grade prostate cancer appears in labeling of the 5 mg formulation. Pregnant people must not handle crushed or broken tablets due to fetal risk. Discuss fertility concerns, liver disease and all other medicines with the prescriber.
Finalo 1 mg, Finax 1 mg, Proscar 5 mg and Avodart 0.5 mg are separate entries; do not switch based solely on strength.
U.S. DailyMed prescribing information
Finasteride 5 mg is approved to treat symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate; it is not the standard approved hair-loss strength.
It inhibits type 2 5-alpha-reductase, reducing production of dihydrotestosterone (DHT).
Improvement in urinary symptoms from BPH can take several months.
Reduced libido, erectile difficulties and ejaculation changes have been reported. Discuss persistent effects with a clinician.
Depression and mood changes have been reported. Seek clinical help for mood symptoms or suicidal thoughts.
These U.S. oral finasteride presentations are not indicated for use in women. Pregnant people must not handle broken or crushed tablets.
Sometimes clinicians prescribe different treatments together, but suitability depends on the diagnosis, formulation and medical risks.
BPH symptoms can recur. Review any change with the prescriber.
Yes. It lowers PSA levels and can alter interpretation of prostate screening; tell your clinician before testing.
No. They differ in enzyme inhibition, approved indications and safety considerations; do not substitute without medical advice.
Cureiva provides product information and handles enquiries where legally permitted, subject to prescription requirements and destination-country laws. Educational content is based on regulatory labeling and is not a claim of individualized medical review. Updated October 2026.